Results 151 to 160 of about 74,855 (209)

High prevalence of SARS-CoV-2 antibodies among frontline healthcare workers during the COVID-19 pandemic in three states of Nigeria from August to December 2022. [PDF]

open access: yesPLoS One
Iriemenam NC   +19 more
europepmc   +1 more source

[Seropositive syphilis in pregnancy].

open access: yesTidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2004
openaire   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Disclosure of HIV seropositivity

Journal of Clinical Psychology, 1999
Deciding whether or not to disclose one's HIV-positive status to another person is an important decision: the way each person experiences and copes with the illness is reflected in this choice. We conducted a study of 174 patients (29.3% of women) to examine how the decision to disclose or conceal was made, as well as its subjective and social ...
A, Lévy   +6 more
openaire   +2 more sources

MANAGEMENT OF RETINOBLASTOMA WITH HIV SEROPOSITIVITY

RETINAL Cases & Brief Reports, 2020
Purpose: To report a case of retinoblastoma with concomitant association with HIV seropositivity and its management. Methods: A retrospective case report of a 3-year-old male child presenting with right eye Group B and left eye Group E retinoblastoma with simultaneous positivity for
Abhinav, Dhami   +2 more
openaire   +2 more sources

Leptospiral infection and seropositivity in rodents

Preventive Veterinary Medicine, 2004
Leblebicioglu, Hakan/0000-0002-6033 ...
Leblebicioglu, H, Sunbul, M
openaire   +2 more sources

Seropositivity for HIV at Alternate Sites

JAMA: The Journal of the American Medical Association, 1988
To the Editor.— Shortly after the Food and Drug Administration licensed thetubeenzyme-linked immunosorbent assay for human immunodeficiency virus (HIV) testing, the Centers for Disease Control made funds available for the development and implementation of "alternate testing sites." The goal of the program was to protect the nation's blood supply by ...
J C, Grabau, D L, Morse
openaire   +2 more sources

HIV-seropositive thrombocytopenia

AIDS, 1991
The action of zidovudine when administered to individuals with severe HIV thrombocytopenia was investigated. Four individuals with platelets less than 50 x 10(9)/l and CD4 cells greater than 200 x 10(6)/l were treated with 600 mg zidovudine per day for 6 weeks, no drug for 6 weeks, 1200 mg zidovudine per day for 6 weeks, then no drug for 6 weeks ...
A, Boyar, G, Beall
openaire   +2 more sources

Home - About - Disclaimer - Privacy